These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21137047)

  • 1. Banking of clinical samples for proteomic biomarker studies: a consideration of logistical issues with a focus on pre-analytical variation.
    Jackson DH; Banks RE
    Proteomics Clin Appl; 2010 Mar; 4(3):250-70. PubMed ID: 21137047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tools to assess tissue quality.
    Neumeister VM
    Clin Biochem; 2014 Mar; 47(4-5):280-7. PubMed ID: 24565988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experience with establishment and operation of a biobank].
    Stege A; Hummel M
    Pathologe; 2008 Nov; 29 Suppl 2():214-7. PubMed ID: 18712392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
    Phan JH; Quo CF; Wang MD
    Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples.
    Rai AJ; Gelfand CA; Haywood BC; Warunek DJ; Yi J; Schuchard MD; Mehigh RJ; Cockrill SL; Scott GB; Tammen H; Schulz-Knappe P; Speicher DW; Vitzthum F; Haab BB; Siest G; Chan DW
    Proteomics; 2005 Aug; 5(13):3262-77. PubMed ID: 16052621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The haematological biobank--an infrastructure for quality assurance, development and research].
    Johnsen HE; Pilgaard L; Højfeldt AD; Andersson TL; Schmitz A; Gade KH; Fogd K; Nyegaard M; Bøgsted M; Dybkær K
    Ugeskr Laeger; 2011 May; 173(21):1489-93. PubMed ID: 21627910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia.
    Forshed J; Pernemalm M; Tan CS; Lindberg M; Kanter L; Pawitan Y; Lewensohn R; Stenke L; Lehtiö J
    J Proteome Res; 2008 Jun; 7(6):2332-41. PubMed ID: 18452325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ethical review of biobanks in The Netherlands: lessons from the String of Pearls Initiative].
    Boeckhout M; van Dijk J; Legemate DA
    Ned Tijdschr Geneeskd; 2011; 155(26):A3557. PubMed ID: 21767425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles.
    Calvano CD; Aresta A; Iacovone M; De Benedetto GE; Zambonin CG; Battaglia M; Ditonno P; Rutigliano M; Bettocchi C
    J Pharm Biomed Anal; 2010 Mar; 51(4):907-14. PubMed ID: 19939598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Liquid nitrogen biobank: a resource for biomedical research].
    Turchi S; Mercuri A; Lazzerini G; Chiesa MR; Musacchio L; Tozzi S; Boni M; Zirilli O; Andreassi MG
    Recenti Prog Med; 2012 Sep; 103(9):307-12. PubMed ID: 23023017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposed BioRepository platform solution for the ALS research community.
    Sherman A; Bowser R; Grasso D; Power B; Milligan C; Jaffa M; Cudkowicz M
    Amyotroph Lateral Scler; 2011 Jan; 12(1):11-6. PubMed ID: 21128868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A European survey on biobanks: trends and issues.
    Zika E; Paci D; Braun A; Rijkers-Defrasne S; Deschênes M; Fortier I; Laage-Hellman J; Scerri CA; Ibarreta D
    Public Health Genomics; 2011; 14(2):96-103. PubMed ID: 20395653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Industrialized MS-based proteomics in the search for circulating biomarkers.
    Migneault I; Hunter JM
    Bioanalysis; 2009 Sep; 1(6):1149-63. PubMed ID: 21083081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentric study of the effect of pre-analytical variables in the quality of plasma samples stored in biobanks using different complementary proteomic methods.
    Mateos J; Carneiro I; Corrales F; Elortza F; Paradela A; Del Pino MS; Iloro I; Marcilla M; Mora MI; Valero L; Ciordia S; Fernández V; Fortuño MA; García-Sánchez I; Martínez R; Muñoz MA; Rodriguez C; Doménech N;
    J Proteomics; 2017 Jan; 150():109-120. PubMed ID: 27620695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The case of biobank with the law: between a legal and scientific fiction.
    Sándor J; Bárd P; Tamburrini C; Tännsjö T
    J Med Ethics; 2012 Jun; 38(6):347-50. PubMed ID: 21947810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical proteomics: the promises and challenges of mass spectrometry-based biomarker discovery.
    deVera IE; Katz JE; Agus DB
    Clin Adv Hematol Oncol; 2006 Jul; 4(7):541-9. PubMed ID: 17147241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery.
    Raimondo F; Morosi L; Chinello C; Magni F; Pitto M
    Proteomics; 2011 Feb; 11(4):709-20. PubMed ID: 21241021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human side of cancer biobanking.
    Gaffney EF; Madden D; Thomas GA
    Methods Mol Biol; 2012; 823():59-77. PubMed ID: 22081339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Constitution of a bank of biological material. Practical aspects].
    Henny J
    Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 2):127-36. PubMed ID: 12684569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An empirical survey on biobanking of human genetic material and data in six EU countries.
    Hirtzlin I; Dubreuil C; Préaubert N; Duchier J; Jansen B; Simon J; Lobato De Faria P; Perez-Lezaun A; Visser B; Williams GD; Cambon-Thomsen A;
    Eur J Hum Genet; 2003 Jun; 11(6):475-88. PubMed ID: 12774042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.